Correlation Between Coya Therapeutics, and Ascletis Pharma
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and Ascletis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and Ascletis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and Ascletis Pharma, you can compare the effects of market volatilities on Coya Therapeutics, and Ascletis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of Ascletis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and Ascletis Pharma.
Diversification Opportunities for Coya Therapeutics, and Ascletis Pharma
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Coya and Ascletis is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and Ascletis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascletis Pharma and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with Ascletis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascletis Pharma has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and Ascletis Pharma go up and down completely randomly.
Pair Corralation between Coya Therapeutics, and Ascletis Pharma
Given the investment horizon of 90 days Coya Therapeutics, Common is expected to under-perform the Ascletis Pharma. In addition to that, Coya Therapeutics, is 1.08 times more volatile than Ascletis Pharma. It trades about -0.29 of its total potential returns per unit of risk. Ascletis Pharma is currently generating about -0.21 per unit of volatility. If you would invest 21.00 in Ascletis Pharma on September 13, 2024 and sell it today you would lose (3.00) from holding Ascletis Pharma or give up 14.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Coya Therapeutics, Common vs. Ascletis Pharma
Performance |
| Timeline |
| Coya Therapeutics, Common |
| Ascletis Pharma |
Coya Therapeutics, and Ascletis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Coya Therapeutics, and Ascletis Pharma
The main advantage of trading using opposite Coya Therapeutics, and Ascletis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, Ascletis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascletis Pharma will offset losses from the drop in Ascletis Pharma's long position.| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
| Ascletis Pharma vs. Sino Biopharmaceutical Ltd | Ascletis Pharma vs. Defence Therapeutics | Ascletis Pharma vs. Aileron Therapeutics | Ascletis Pharma vs. Enlivex Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |